AIM™ – Effectively adds an expert neurophysiologist to the team
Understaffed due to a shortage in experts and lengthy training, surgeries would occasionally be postponed or even cancelled altogether. Upon the maturation of artificial intelligence, he envisioned replicating his and other expert neurophysiologist’s knowhow into an AI software that would assist him and his team in addressing these challenges that are also encountered worldwide. Together with brother Nir, they established Nervio in early 2020 to create the AIMTM proprietary technology which is set to benefit over 700K yearly monitored surgeries in the US alone in a $3.3B market growing at 4.9% CAGR.